Core Viewpoint - Hengan International (01044.HK) reported a revenue of RMB 23.069 billion for the fiscal year ending December 31, 2025, reflecting a year-on-year growth of 1.8%, with a net profit attributable to shareholders of RMB 2.535 billion, up 10.3% [1][2]. Group 1: Financial Performance - The group's main business revenue, including tissue and hygiene product sales, reached RMB 20.740 billion, marking a 1.9% increase year-on-year [1]. - Basic earnings per share were RMB 2.227, with a proposed final dividend of RMB 0.70 per share [1]. - Overall gross profit increased by approximately 6.6% to around RMB 7.806 billion, with an improved gross margin of about 33.8% for the year [4]. Group 2: Market Dynamics - The domestic consumer goods market is experiencing intensified competition, particularly in the tissue industry, leading to the consolidation of smaller enterprises [2]. - Despite high margins in the hygiene products market, ongoing price competition remains a challenge [2]. Group 3: Strategic Initiatives - The company is adapting to industry trends by focusing on personal care product upgrades and expanding new retail channels, employing a stable pricing strategy and product premiumization [2][3]. - E-commerce and new retail sales grew by 10.1%, accounting for 36.9% of total sales, driven by the demand for immediate supply of daily necessities [3]. - The introduction of high-end products, such as the "Tianshan Velvet Cotton" sanitary napkin series and the "Q ? MO" premium diaper series, has contributed to strong sales momentum and enhanced profitability [3]. Group 4: Future Outlook - The company anticipates continued pressure on the operating environment in 2026, but expects steady growth in tissue sales to bolster profit resilience [2]. - Strategic allocation of sales expenses and the growth of high-margin premium products are expected to mitigate the impact of raw material price fluctuations on gross profit [4].
恒安国际(01044.HK)年度纯利增长10.3%至25.35亿元 末期息0.7元